Targeting cellular metabolism to improve cancer therapeutics
Yinglan Zhao(Sichuan University), Ming Tan(USA Mitchell Cancer Institute)
Cited by 1,000
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Tumor biomarkers for diagnosis, prognosis and targeted therapy
|Signal Transduction and Targeted Therapy|2024|600
Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism
|Frontiers in Immunology|2018|459
MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
|Journal of Biological Chemistry|2010|429
Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
|Cancer Research|2011|291